Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

MEDICATION INFORMATION

GENERIC NAME TRADE NAMES CLASSIFICATION

Vecuronium

Norcuron
PEAK

Nondepolarizing NMBD (intermediate acting)


ONSET DURATION

NORMAL DOSAGE RANGE (ALSO INCLUDE ROUTE AND FREQUENCY)

3-5 min

2.5-3 min

25-40 min

Pediatric -IV: 0.08-0.1 mg/kg Adult- IV: 0.08-0.1 mg/kg Continuous infusion: 0.1 mg/kg/hr
LAB VALUE ALTERATIONS None listed DRUG INTERACTIONS

Aminoglycosides, Calcium channel blockers, clindamycin, cyclophosphamide, cyclosporine ,dantrolene ,furosemide, Inhalation anesthetics ,Local anesthetics,magnesium ,polymyxin, procainamide ,quinidine
Why is your patient getting this medication? Or What are some reasons that these medications are ordered? Pediatric- Intubation

MECHANISM OF ACTION (How does it work?)

Nondepolarizing NMBDs also bind to ACh receptors at the neuromuscular junction, but instead of mimicking ACh, they block its usual actions. Therefore, these drugs are competitive antagonists of ACh. Consequently, the nerve cell membrane is not depolarized, the muscle fibers are not stimulated, and skeletal muscle contraction does not occur.
COMMON SIDE EFFECTS

Adult- Mechanical ventilation

Musculoskeletal: skeletal muscle weakness. Respiratory: prolonged, dose-related respiratory insufficiency or apnea.

NURSING IMPLICATIONS (What to focus on.)

TEACHING

PREADMINISTRATION ASSESSMENT?

WHEN/WHY WOULD YOU HOLD?

WHAT WOULD YOU ASSESS POSTADMINISTRATION?

You might also like